Developing Growth Fund
Daily price w/o sales charge as of 05/29/2020
$27.09
$0.30
YTD Returns w/o sales charge as of 05/29/2020
9.99%
Overall Morningstar RatingsSmall Growth
as of 04/30/2020
Morningstar rated the Lord Abbett Developing Growth Fund class R6 share 5 stars among 581 Small Growth Funds for the overall rating and the 3 year periods ended 4/30/2020, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.
Fund Basicsas of 04/30/2020
- Total Net Assets
- $1.78 B
- Inception Date
- 06/30/2015
- Dividend Frequency
- Annually
- Fund Expense Ratio
- 0.60%
- Number of Holdings
- 97
Fund Expense Ratio :
0.60%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | -3.05% | -1.48% | 17.31% | 8.75% | 13.33% | - |
| Lipper Category Avg. Small-Cap Growth Funds | -11.79% | -7.20% | 6.97% | 6.62% | 10.22% | - |
| Russell 2000® Growth Index | -14.71% | -9.22% | 4.21% | 5.19% | 9.96% | - |
Fund Expense Ratio :
0.60%
Fund Expense Ratio :
0.60%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | -16.85% | -13.41% | 11.74% | 4.75% | 11.90% | - |
| Lipper Category Avg. Small-Cap Growth Funds | -23.79% | -16.89% | 2.48% | 3.05% | 9.06% | - |
| Russell 2000® Growth Index | -25.76% | -18.58% | 0.10% | 1.70% | 8.89% | - |
Fund Expense Ratio :
0.60%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 04/30/2020View Portfolio
| Holding | Assets |
|---|---|
| Inphi Corp. | 2.7% |
| Five9, Inc. | 2.5% |
| Monolithic Power Systems, Inc. | 2.2% |
| Generac Holdings, Inc. | 2.1% |
| Chegg, Inc. | 2.0% |
| Teladoc Health | 1.8% |
| Wingstop, Inc. | 1.7% |
| Everbridge, Inc. | 1.7% |
| YETI Holdings Inc | 1.6% |
| SVMK Inc | 1.6% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 04/30/2020View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
0.60%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | -3.05% | -1.48% | 17.31% | 8.75% | 13.33% | - |
| Lipper Category Avg. Small-Cap Growth Funds | -11.79% | -7.20% | 6.97% | 6.62% | 10.22% | - |
| Russell 2000® Growth Index | -14.71% | -9.22% | 4.21% | 5.19% | 9.96% | - |
Fund Expense Ratio :
0.60%
Fund Expense Ratio :
0.60%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | -16.85% | -13.41% | 11.74% | 4.75% | 11.90% | - |
| Lipper Category Avg. Small-Cap Growth Funds | -23.79% | -16.89% | 2.48% | 3.05% | 9.06% | - |
| Russell 2000® Growth Index | -25.76% | -18.58% | 0.10% | 1.70% | 8.89% | - |
Fund Expense Ratio :
0.60%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2019 | 32.40% | 28.48% |
| 2018 | 5.42% | -9.31% |
| 2017 | 30.39% | 22.17% |
| 2016 | -2.33% | 11.32% |
| 2015 | -8.49% | -1.38% |
| 2014 | 3.70% | 5.60% |
| 2013 | 57.99% | 43.30% |
| 2012 | 10.88% | 14.59% |
| 2011 | -1.16% | -2.91% |
| 2010 | 37.21% | 29.09% |
| 2009 | 47.74% | - |
| 2008 | -47.24% | - |
| 2007 | 36.48% | - |
| 2006 | 13.02% | - |
| 2005 | 12.47% | - |
| 2004 | 6.54% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2020 | -16.85% | - | - | - | 9.99% |
| 2019 | 27.13% | 9.20% | -11.28% | 7.50% | 32.40% |
| 2018 | 7.25% | 15.05% | 12.26% | -23.89% | 5.42% |
| 2017 | 8.48% | 4.13% | 7.16% | 7.73% | 30.39% |
| 2016 | -10.23% | 2.33% | 10.98% | -4.20% | -2.33% |
| 2015 | 7.22% | 2.73% | -15.60% | -1.57% | -8.49% |
| 2014 | 1.80% | 0.28% | -5.68% | 7.70% | 3.70% |
| 2013 | 13.64% | 10.16% | 18.92% | 6.12% | 57.99% |
| 2012 | 12.28% | -2.56% | 5.70% | -4.12% | 10.88% |
| 2011 | 10.36% | 1.64% | -20.75% | 11.20% | -1.16% |
| 2010 | 8.29% | -7.81% | 16.65% | 17.83% | 37.21% |
| 2009 | -2.02% | 24.54% | 14.28% | 5.95% | 47.74% |
| 2008 | -21.72% | 6.73% | -11.66% | -28.51% | -47.24% |
| 2007 | 4.79% | 13.71% | 10.00% | 4.13% | 36.48% |
| 2006 | 16.11% | -6.10% | -6.71% | 11.12% | 13.02% |
| 2005 | -5.73% | 5.89% | 9.75% | 2.66% | 12.47% |
| 2004 | - | - | - | 11.67% | 6.54% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Inphi Corp. | Information Technology | 2.7% |
| Five9, Inc. | Information Technology | 2.5% |
| Monolithic Power Systems, Inc. | Information Technology | 2.2% |
| Generac Holdings, Inc. | Industrials | 2.1% |
| Chegg, Inc. | Consumer Discretionary | 2.0% |
| Teladoc Health | Health Care | 1.8% |
| Wingstop, Inc. | Consumer Discretionary | 1.7% |
| Everbridge, Inc. | Information Technology | 1.7% |
| YETI Holdings Inc | Consumer Discretionary | 1.6% |
| SVMK Inc | Information Technology | 1.6% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Inphi Corp. | Information Technology | 2.8% |
| eHealth, Inc. | Financials | 2.6% |
| Five9, Inc. | Information Technology | 2.4% |
| Generac Holdings, Inc. | Industrials | 2.4% |
| Teladoc Health | Health Care | 2.3% |
| Monolithic Power Systems, Inc. | Information Technology | 2.2% |
| Chegg, Inc. | Consumer Discretionary | 2.0% |
| Axon Enterprise, Inc. | Industrials | 1.6% |
| Everbridge, Inc. | Information Technology | 1.6% |
| Nevro Corp. | Health Care | 1.6% |
| SVMK Inc | Information Technology | 1.6% |
| Avalara Inc | Information Technology | 1.6% |
| Repligen Corp. | Health Care | 1.6% |
| Masimo Corp. | Health Care | 1.5% |
| YETI Holdings Inc | Consumer Discretionary | 1.5% |
| Federal Signal Corp. | Industrials | 1.5% |
| Forty Seven Inc | Health Care | 1.5% |
| Freshpet, Inc. | Consumer Staples | 1.4% |
| Inspire Medical Systems Inc | Health Care | 1.4% |
| Lumentum Holdings, Inc. | Information Technology | 1.4% |
| Wingstop, Inc. | Consumer Discretionary | 1.4% |
| Bridgebio Pharma Inc | Health Care | 1.4% |
| SolarEdge Technologies, Inc. | Information Technology | 1.4% |
| Strategic Education, Inc. | Consumer Discretionary | 1.4% |
| Insulet Corp. | Health Care | 1.4% |
| Mirati Therapeutics, Inc. | Health Care | 1.3% |
| MKS Instruments, Inc. | Information Technology | 1.3% |
| Argenx SE | Health Care | 1.3% |
| Redfin Corp | Real Estate | 1.3% |
| Penumbra, Inc. | Health Care | 1.3% |
| Paylocity Holding Corp. | Information Technology | 1.3% |
| Helen of Troy Ltd. | Consumer Discretionary | 1.2% |
| Coupa Software Inc | Information Technology | 1.2% |
| Tetra Tech, Inc. | Industrials | 1.2% |
| Globant SA | Information Technology | 1.1% |
| Trex Co., Inc. | Industrials | 1.1% |
| Acceleron Pharma, Inc. | Health Care | 1.1% |
| Alteryx Inc | Information Technology | 1.1% |
| LGI Homes, Inc. | Consumer Discretionary | 1.1% |
| Boston Beer Co., Inc. | Consumer Staples | 1.0% |
| 10X Genomics Inc | Health Care | 1.0% |
| Assetmark Financial Holdings Inc | Financials | 1.0% |
| Guardant Health Inc | Health Care | 1.0% |
| Sarepta Therapeutics, Inc. | Health Care | 1.0% |
| ChemoCentryx Inc | Health Care | 0.9% |
| iRhythm Technologies, Inc. | Health Care | 0.9% |
| Iovance Biotherapeutics Inc | Health Care | 0.9% |
| Cirrus Logic, Inc. | Information Technology | 0.9% |
| Goosehead Insurance Inc | Financials | 0.8% |
| Blueprint Medicines Corp. | Health Care | 0.8% |
| Malibu Boats, Inc. | Consumer Discretionary | 0.8% |
| Blackline, Inc. | Information Technology | 0.8% |
| FTI Consulting, Inc. | Industrials | 0.8% |
| Bright Horizons Family Solutions, Inc. | Consumer Discretionary | 0.8% |
| Turning Point Therapeutics Inc | Health Care | 0.8% |
| Quanta Services, Inc. | Industrials | 0.8% |
| Universal Display Corp. | Information Technology | 0.7% |
| Deckers Outdoor Corp. | Consumer Discretionary | 0.7% |
| Evoqua Water Technologies Corp | Industrials | 0.7% |
| Q2 Holdings, Inc. | Information Technology | 0.7% |
| Appian Corp | Information Technology | 0.7% |
| Karuna Therapeutics Inc | Health Care | 0.7% |
| Novanta Inc | Information Technology | 0.7% |
| Grocery Outlet Holding Corp | Consumer Staples | 0.7% |
| Planet Fitness, Inc. | Consumer Discretionary | 0.6% |
| CRISPR Therapeutics AG | Health Care | 0.6% |
| Axonics Modulation Technologies Inc | Health Care | 0.6% |
| National Vision Holdings Inc | Consumer Discretionary | 0.6% |
| Semtech Corp. | Information Technology | 0.6% |
| Rocket Pharmaceuticals Inc | Health Care | 0.6% |
| Silicon Laboratories, Inc. | Information Technology | 0.6% |
| Arena Pharmaceuticals, Inc. | Health Care | 0.6% |
| Aerovironment, Inc. | Industrials | 0.6% |
| HubSpot, Inc. | Information Technology | 0.6% |
| MasTec, Inc. | Industrials | 0.6% |
| Coherus Biosciences, Inc. | Health Care | 0.5% |
| Zymeworks Inc | Health Care | 0.5% |
| PTC Therapeutics, Inc. | Health Care | 0.5% |
| Natera, Inc. | Health Care | 0.5% |
| Etsy, Inc. | Consumer Discretionary | 0.5% |
| Pagseguro Digital Ltd | Information Technology | 0.5% |
| GW Pharmaceuticals plc | Health Care | 0.5% |
| Western Alliance Bancorp | Financials | 0.5% |
| Peloton Interactive Inc | Consumer Discretionary | 0.5% |
| NextCure Inc | Health Care | 0.5% |
| uniQure NV | Health Care | 0.5% |
| XPO Logistics, Inc. | Industrials | 0.5% |
| Medallia Inc | Information Technology | 0.5% |
| Lyft Inc | Industrials | 0.5% |
| Deciphera Pharmaceuticals Inc | Health Care | 0.4% |
| Cardlytics Inc | Information Technology | 0.4% |
| Carvana Co | Consumer Discretionary | 0.4% |
| Myovant Sciences Ltd | Health Care | 0.3% |
| Limelight Networks, Inc. | Information Technology | 0.2% |
| Endava PLC | Information Technology | 0.1% |
| Comtech Telecommunications Corp. | Information Technology | 0.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 04/30/2020
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services | 0.0% | |
| Real Estate |
0.2%
|
|
| Utilities | 0.0% | |
| Consumer Discretionary |
1.6%
|
|
| Consumer Staples |
0.1%
|
|
| Energy | 0.0% | |
| Financials |
 2.0%
|
|
| Health Care |
2.0%
|
|
| Industrials |
0.2%
|
|
| Information Technology |
2.3%
|
|
| Materials | 0.0% |
Portfolio Details as of 04/30/2020
- Total Net Assets
- $1.78 B
- Number of Holdings
- 97
- Weighted Average Market Cap.
- 4.7 B
- P/B Ratio
- 6.3x
- P/E Ratio
- 28.8x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 03/31/2020
Contributors
| Holding | Contribution |
|---|---|
| Teladoc, Inc. | 1.0% |
| Forty Seven Inc | 1.0% |
| eHealth, Inc. | 0.6% |
| Acceleron Pharma, Inc. | 0.4% |
| Five9, Inc. | 0.3% |
Detractors
| Holding | Contribution |
|---|---|
| Yeti Hldgs Inc | -1.0% |
| Eldorado Resorts, Inc. | -0.7% |
| Mirati Therapeutics, Inc. | -0.7% |
| Planet Fitness, Inc. | -0.7% |
| Western Alliance Bancorp | -0.7% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Developing Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2020 | 11/24/2020 | 11/24/2020 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/20/2019 | 11/21/2019 | $4.4885 | - | $4.4885 | $23.54 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/23/2020 | 11/24/2020 |
Fees & Expenses
Fees & Expenses
Expense Ratioas of 04/30/2020
| 0.60% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||